血清sST2、FGF-23、GDF-15对阵发性房颤的预测价值探讨
Prognostic Value of Serum sST2, FGF-23 and GDF-15 in Paroxysmal Atrial Fibrillation
DOI: 10.12677/acm.2024.1492525, PDF,   
作者: 赵立新, 朱 清*:络病理论创新转化全国重点实验室;教育部和国家卫健委心血管重构与功能研究重点实验室;山东大学齐鲁医院心内科,山东 济南
关键词: 心房颤动可溶性生长刺激基因表达蛋白2成纤维细胞生长因-23生长分化因子-15Atrial Fibrillation Soluble Growth Stimulating Gene Expression Protein 2 Fibroblast Gowth Factor-23 Growth Differentiation Factor 15
摘要: 目的:检测阵发性心房颤动(Paroxysmal Atrial Fibrillation, PAF)患者与非心房颤动(Atrial Fibrillation, AF)患者血清可溶性生长刺激基因表达蛋白2 (Soluble Growth Stimulating Gene Expression Protein 2, sST2)、成纤维细胞生长因子-23 (Fibroblast Gowth Factor-23, FGF-23)、人生长分化因子15 (Growth differentiation factor 15, GDF-15)水平,探讨此三个因子对PAF的预测价值。方法:选取符合入排标准的PAF患者61例作为观察组,非AF患者61例作为对照组。应用酶联吸附免疫实验法(Enzyme linked immunosorbent assay, ELISA)测定两组患者血清sST2、FGF-23、GDF-15的浓度。比较两组患者的临床资料、血液学检测指标。采用Spearman相关性分析sST2、FGF-23、GDF-15与炎症指标及其与超声心动图各参数的相关性。采用单因素及多因素logistic回归分析PAF发生的相关因素。结果:与非AF组比较,PAF组血清sST2、FGF-23、GDF-15水平均明显升高(P < 0.05)。Spearman相关性分析显示,血清sST2与FGF-23呈正相关(r = 0.219, P = 0.015),sST2与GDF-15呈正相关(r = 0.211, P = 0.020),FGF-23与GDF-15呈正相关(r = 0.198, P = 0.028)。sST2与中性粒细胞呈正相关(r = 0.268, P = 0.003)、与NLR呈正相关(r = 0.265, P = 0.003),与白细胞、淋巴细胞无显著相关性;FGF-23、GDF-15与炎症指标均无显著相关性。sST2、FGF-23、GDF-15均与超声心动图各参数无显著相关性。单因素logistic回归分析显示,年龄、心率、舒张压、左房前后径、右房长径、右房横径、sST2、FGF-23、GDF-15、谷丙转氨酶、总胆红素、直接胆红素、肌酐、肾小球滤过率、高密度脂蛋白胆固醇(P < 0.05)是PAF的危险因素。多因素logistic回归分析显示,年龄(OR = 1.197, 95%CI 1.066~1.343, P = 0.002)、FGF-23 (OR = 1.006, 95%CI 1.002~1.011, P = 0.009)、GDF-15 (OR = 1.003, 95%CI 1.001~1.005, P < 0.001)、高密度脂蛋白胆固醇(OR = 19.136, 95%CI 1.050~348.601, P = 0.046)是PAF的独立危险因素。结论:1) PAF组血清sST2、FGF-23、GDF-15水平较非AF组明显升高,多因素logistic回归分析显示FGF-23、GDF-15是PAF的独立危险因素。2) 血清sST2、FGF-23、GDF-15浓度两两呈正相关性,sST2与中性粒细胞、NLR呈正相关性,提示炎症反应参与了PAF的发生发展。3) 血清sST2、FGF-23、GDF-15水平均与超声心动图参数无显著相关性,其与房颤发生的相关性可能独立于心脏结构改变之外。
Abstract: Objective: To detect the levels of serum sST2, FGF-23 and GDF-15 in patients with PAF and without AF, and investigate the predictive value of these three factors on PAF. Methods: 61 patients with PAF who met the inclusion criteria were selected as the observation group, and 61 patients without AF were selected as the control group. Serum levels of sST2, FGF-23 and GDF-15 were determined by ELISA. The clinical data and hematological indicators of the two groups were compared. Spearman correlation analysis was used to analyze the correlation between sST2, FGF-23, GDF-15 and inflammatory indicators and echocardiographic parameters. The factors related to the occurrence of PAF were analyzed by univariate and multivariate logistic regression. Results: Compared with non-AF group, serum levels of sST2, FGF-23 and GDF-15 in PAF group were significantly increased (P < 0.05). Spearman correlation analysis showed that serum sST2 was positively correlated with FGF-23 (r = 0.219, P = 0.015), and sST2 was positively correlated with GDF-15 (r = 0.211, P = 0.020). FGF-23 was positively correlated with GDF-15 (r = 0.198, P = 0.028). sST2 was positively correlated with neutrophils (r = 0.268, P = 0.003) and NLR (r = 0.265, P = 0.003), but had no significant correlation with leukocytes and lymphocytes. There was no significant correlation between FGF-23, GDF-15 and inflammatory indexes. sST2, FGF-23 and GDF-15 were not significantly correlated with echocardiographic parameters. Univariate logistic regression analysis showed that age, heart rate, diastolic blood pressure, left anteroposterior atrial diameter, right atrial long diameter, right atrial transverse diameter, sST2, FGF-23, GFF-15, alanine aminotransferase, total bilirubin, direct bilirubin, creatinine, glomerular filtration rate, and high density lipoprotein cholesterol were risk factors for PAF (P < 0.05). Multivariate logistic regression analysis showed that Age (OR = 1.197, 95%CI 1.066~1.343, P = 0.002), FGF-23 (OR = 1.006, 95%CI 1.002~1.011, P = 0.009), GDF-15 (OR = 1.003, 95%CI 1.001~1.005, P < 0.001), high density lipoprotein cholesterol (OR = 19.136, 95%CI 1.050~348.601, P = 0.046) were independent risk factors for PAF. Conclusion: 1) Serum levels of sST2, FGF-23 and GDF-15 in PAF group were significantly higher than those in non-AF group, and multiple logistic regression analysis showed that FGF-23 and GDF-15 were independent risk factors for PAF. 2) Serum sST2, FGF-23 and GDF-15 concentrations were positively correlated, and sST2 was positively correlated with neutrophils and NLR, suggesting that inflammation was involved in the occurrence and development of PAF. 3) Serum sST2, FGF-23 and GDF-15 levels were not significantly correlated with echocardiographic parameters, and their correlation with atrial fibrillation may be independent of cardiac structural changes.
文章引用:赵立新, 朱清. 血清sST2、FGF-23、GDF-15对阵发性房颤的预测价值探讨[J]. 临床医学进展, 2024, 14(9): 745-757. https://doi.org/10.12677/acm.2024.1492525

参考文献

[1] Chung, M.K., Refaat, M., Shen, W., Kutyifa, V., Cha, Y., Di Biase, L., et al. (2020) Atrial Fibrillation. Journal of the American College of Cardiology, 75, 1689-1713. [Google Scholar] [CrossRef] [PubMed]
[2] Andrade, J., Khairy, P., Dobrev, D. and Nattel, S. (2014) The Clinical Profile and Pathophysiology of Atrial Fibrillation. Circulation Research, 114, 1453-1468. [Google Scholar] [CrossRef] [PubMed]
[3] Li, C., Zhang, J., Hu, W. and Li, S. (2020) Atrial Fibrosis Underlying Atrial Fibrillation (review). International Journal of Molecular Medicine, 47, Article No. 9. [Google Scholar] [CrossRef] [PubMed]
[4] Karam, B.S., Chavez-Moreno, A., Koh, W., Akar, J.G. and Akar, F.G. (2017) Oxidative Stress and Inflammation as Central Mediators of Atrial Fibrillation in Obesity and Diabetes. Cardiovascular Diabetology, 16, Article No. 120. [Google Scholar] [CrossRef] [PubMed]
[5] Dudink, E.A. (2018) The Biomarkers NT-proBNP and CA-125 Are Elevated in Patients with Idiopathic Atrial Fibrillation. Journal of Atrial Fibrillation, 11, Article 2058. [Google Scholar] [CrossRef] [PubMed]
[6] Aimo, A., Januzzi, J.L., Bayes-Genis, A., Vergaro, G., Sciarrone, P., Passino, C., et al. (2019) Clinical and Prognostic Significance of sST2 in Heart Failure. Journal of the American College of Cardiology, 74, 2193-2203. [Google Scholar] [CrossRef] [PubMed]
[7] Grabner, A., Amaral, A.P., Schramm, K., Singh, S., Sloan, A., Yanucil, C., et al. (2015) Activation of Cardiac Fibroblast Growth Factor Receptor 4 Causes Left Ventricular Hypertrophy. Cell Metabolism, 22, 1020-1032. [Google Scholar] [CrossRef] [PubMed]
[8] Grabner, A., Schramm, K., Silswal, N., Hendrix, M., Yanucil, C., Czaya, B., et al. (2017) FGF23/FGFR4-Mediated Left Ventricular Hypertrophy Is Reversible. Scientific Reports, 7, Article No. 1993. [Google Scholar] [CrossRef] [PubMed]
[9] Koller, L., Kleber, M.E., Brandenburg, V.M., Goliasch, G., Richter, B., Sulzgruber, P., et al. (2015) Fibroblast Growth Factor 23 Is an Independent and Specific Predictor of Mortality in Patients with Heart Failure and Reduced Ejection Fraction. Circulation: Heart Failure, 8, 1059-1067. [Google Scholar] [CrossRef] [PubMed]
[10] Arkoumani, M., Papadopoulou-Marketou, N., Nicolaides, N.C., Kanaka-Gantenbein, C., Tentolouris, N. and Papassotiriou, I. (2019) The Clinical Impact of Growth Differentiation Factor-15 in Heart Disease: A 2019 Update. Critical Reviews in Clinical Laboratory Sciences, 57, 114-125. [Google Scholar] [CrossRef] [PubMed]
[11] Wollert, K.C. and Kempf, T. (2012) Growth Differentiation Factor 15 in Heart Failure: An Update. Current Heart Failure Reports, 9, 337-345. [Google Scholar] [CrossRef] [PubMed]
[12] Staff, A.C., Bock, A.J., Becker, C., Kempf, T., Wollert, K.C. and Davidson, B. (2010) Growth Differentiation Factor-15 as a Prognostic Biomarker in Ovarian Cancer. Gynecologic Oncology, 118, 237-243. [Google Scholar] [CrossRef] [PubMed]
[13] Wallin, U., Glimelius, B., Jirström, K., Darmanis, S., Nong, R.Y., Pontén, F., et al. (2011) Growth Differentiation Factor 15: A Prognostic Marker for Recurrence in Colorectal Cancer. British Journal of Cancer, 104, 1619-1627. [Google Scholar] [CrossRef] [PubMed]
[14] Baek, K.E., Yoon, S.R., Kim, J., Kim, K.S., Kang, S.H., Yang, Y., et al. (2009) Upregulation and Secretion of Macrophage Inhibitory Cytokine-1 (MIC-1) in Gastric Cancers. Clinica Chimica Acta, 401, 128-133. [Google Scholar] [CrossRef] [PubMed]
[15] Resl, M., Clodi, M., Vila, G., Luger, A., Neuhold, S., Wurm, R., et al. (2016) Targeted Multiple Biomarker Approach in Predicting Cardiovascular Events in Patients with Diabetes. Heart, 102, 1963-1968. [Google Scholar] [CrossRef] [PubMed]
[16] Pavo, N., Wurm, R., Neuhold, S., et al. (2016) GDF-15 Is Associated with Cancer Incidence in Patients with Type 2 Diabetes. Clinical Chemistry, 62, 1612-1620. [Google Scholar] [CrossRef] [PubMed]
[17] Tuegel, C., Katz, R., Alam, M., Bhat, Z., Bellovich, K., de Boer, I., et al. (2018) GDF-15, Galectin 3, Soluble ST2, and Risk of Mortality and Cardiovascular Events in CKD. American Journal of Kidney Diseases, 72, 519-528. [Google Scholar] [CrossRef] [PubMed]
[18] 姚超永, 陈宗灿. 非瓣膜性心房颤动患者血清胆红素的变化及意义[J]. 深圳中西医结合杂志, 2017, 27(20): 152-153.
[19] Vianello, E., Dozio, E., Tacchini, L., et al. (2019) ST2/IL-33 Signaling in Cardiac Fibrosis. The International Journal of Biochemistry & Cell Biology, 116, 105619. [Google Scholar] [CrossRef] [PubMed]
[20] Ye, T., Zhang, C., Wu, G., Wan, W., Liang, J., Liu, X., et al. (2019) Pinocembrin Attenuates Autonomic Dysfunction and Atrial Fibrillation Susceptibility via Inhibition of the NF-κB/TNF-α Pathway in a Rat Model of Myocardial Infarction. International Immunopharmacology, 77, Article 105926. [Google Scholar] [CrossRef] [PubMed]
[21] Matilla, L., Arrieta, V., Jover, E., Garcia-Peña, A., Martinez-Martinez, E., Sadaba, R., et al. (2020) Soluble St2 Induces Cardiac Fibroblast Activation and Collagen Synthesis via Neuropilin-1. Cells, 9, Article 1667. [Google Scholar] [CrossRef] [PubMed]
[22] 刘海洋, 刘虹. 成纤维生长因子23与慢性肾病不良预后的关系及治疗策略[J]. 中南大学学报(医学版), 2018, 43(5): 560-565.
[23] Savas, O., Oktay, O., Murat, E., et al. (2016) The Relationship between FGF-23 and Ghrelin Levels in CKD Patients: Preliminary Data. The Italian Journal of Urology and Nephrology, 68, 227-232.
[24] Moe, S.M., Chertow, G.M., Parfrey, P.S., Kubo, Y., Block, G.A., Correa-Rotter, R., et al. (2015) Cinacalcet, Fibroblast Growth Factor-23, and Cardiovascular Disease in Hemodialysis. Circulation, 132, 27-39. [Google Scholar] [CrossRef] [PubMed]
[25] Olauson, H., Qureshi, A.R., Miyamoto, T., Barany, P., Heimburger, O., Lindholm, B., et al. (2010) Relation between Serum Fibroblast Growth Factor-23 Level and Mortality in Incident Dialysis Patients: Are Gender and Cardiovascular Disease Confounding the Relationship? Nephrology Dialysis Transplantation, 25, 3033-3038. [Google Scholar] [CrossRef] [PubMed]
[26] Faul, C., Amaral, A.P., Oskouei, B., Hu, M., Sloan, A., Isakova, T., et al. (2011) FGF23 Induces Left Ventricular Hypertrophy. Journal of Clinical Investigation, 121, 4393-4408. [Google Scholar] [CrossRef] [PubMed]
[27] Wischhusen, J., Melero, I. and Fridman, W.H. (2020) Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint. Frontiers in Immunology, 11, Article 951. [Google Scholar] [CrossRef] [PubMed]
[28] Heger, J., Schiegnitz, E., von Waldthausen, D., Anwar, M.M., Piper, H.M. and Euler, G. (2010) Growth Differentiation Factor 15 Acts Anti-Apoptotic and Pro-Hypertrophic in Adult Cardiomyocytes. Journal of Cellular Physiology, 224, 120-126. [Google Scholar] [CrossRef] [PubMed]
[29] Lamprea-Montealegre, J.A., Zelnick, L.R., Shlipak, M.G., Floyd, J.S., Anderson, A.H., He, J., et al. (2019) Cardiac Biomarkers and Risk of Atrial Fibrillation in Chronic Kidney Disease: The CRIC Study. Journal of the American Heart Association, 8, e012200. [Google Scholar] [CrossRef] [PubMed]
[30] 吴英乐, 程帅锋, 陈润, 等. 血清胆红素水平和房颤的关系[J]. 河南科技大学学报(医学版), 2019, 37(3): 201-204.
[31] 温昌霖, 张忠良, 王国华. 孤立性房颤与心脏结构功能相关性研究[J]. 实用诊断与治疗杂志, 2007, 21(6): 436-437+440.
[32] Xie, E., Yu, R., Ambale-Venkatesh, B., Bakhshi, H., Heckbert, S.R., Soliman, E.Z., et al. (2020) Association of Right Atrial Structure with Incident Atrial Fibrillation: A Longitudinal Cohort Cardiovascular Magnetic Resonance Study from the Multi-Ethnic Study of Atherosclerosis (MESA). Journal of Cardiovascular Magnetic Resonance, 22, 36. [Google Scholar] [CrossRef] [PubMed]
[33] Hasebe, H., Yoshida, K., Iida, M., Hatano, N., Muramatsu, T. and Aonuma, K. (2016) Right-to-Left Frequency Gradient during Atrial Fibrillation Initiated by Right Atrial Ectopies and Its Augmentation by Adenosine Triphosphate: Implications of Right Atrial Fibrillation. Heart Rhythm, 13, 354-363. [Google Scholar] [CrossRef] [PubMed]
[34] 富丽娟, 赵晓静, 胡微, 等. 心房颤动患者血清sST-2、apelin、NT-proBNP、炎症因子浓度与左心房内径的关系[J]. 岭南心血管病杂志, 2019, 25(5): 530-535.
[35] 邢文, 赵春梅, 王德国. 血清成纤维细胞生长因子23与慢性心力衰竭心室重构的相关性[J]. 临床心血管病杂志, 2016, 32(1): 36-39.